The ChAMP (Chondral Lesions And Meniscus Procedures) Trial
Completed · Not applicable
Conditions studied: Meniscal Tear, Chondromalacia
In brief
The purpose of this randomized controlled trial is to determine the effectiveness of treating cartilage lesions found during knee arthroscopy.
Key facts
- Study ID
- NCT01527201
- Run by
- State University of New York at Buffalo
- People needed
- 190
- Starts
- 2012-01-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2021-04-15
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients scheduled to undergo a meniscectomy
- Patients with chondral lesions found during meniscectomy
- Patients without chondral lesions are not eligible for randomization to one of the study arms, but will still be included in the study and observed after surgery
You may not qualify if…
- Osteochondritis dissecans
- Large chondral flaps judged to be impending loose bodies
- Joint space loss of affected compartment greater than 50% compared to opposite side
- Visible osteophytes of the medial or lateral compartment
- Previous knee surgery on the affected side
- Previous major knee trauma
- History of inflammatory joint disease, gout, or chondrocalcinosis
- Presence of worker's compensation claim
- Patients undergoing meniscal repair
- Patients undergoing microfracture for contained grade IV chondral lesions
- Presence of significant ligamentous instability in the operative knee (i.e., complete acruciate ligament (ACL) or posterior cruciate ligament (PCL) tear, grade III medial or lateral side instability)
- Major neurologic deficit
- Serious medical illness with limited life expectancy or that poses high intraoperative risk
- Pregnancy
Where it is running
- UB Orthopaedics and Sports Medicine — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.